주식회사 브이원바이오
건강하고 가치있는 원헬스 생태계를 만들고, 혁신적인 마이크로바이옴 치료제로 전 세계 환자의 삶을 변화시키 위해 설립된 브이원바이오(V1bio)는 동물, 환경, 사람로부터 유용 미생물을 발굴하여 항암 및 면역분야의 혁신적 생균 치료제 (LBP; Live Biotherapeutic Product)를 연구개발하고 있습니다.
브이원바이오는 지속 연구개발과 함께 독자적 연구 플랫폼 고도화로 개발파이프라인을 확보하고, 기술사업화 성공을 통하여, 보다 빠르게 글로벌 마이크로바이옴 치료제 신약개발 전문기업으로 성장하고자 합니다.
Vision
Mission
' Top-tier microbiome biotechology company '
We are dedicated to pursuing groundbreaking microbiome to discover and develop medicines
Mission
Mission
Our mission is to provide the better lives of patients worldwide with revolutionary one health microbiome and solutions
Value
Value
Respect for people, Act with intergrity
Communication with open-minded
Continuous challenge for innovation
Pioneer in utilizing revolutionary microbe as medicine
Proprietary platform
Proprietary platform
Proprietary platform
One health microbiome library
Microbiome profiling (AI & BI)
Multi-omics analysis, Translational research
Focus areas
Proprietary platform
Proprietary platform
Live biotherapeutic product (single strain)
Oncology, Immunology
One health microbiome
Open collaboration
Proprietary platform
Open collaboration
Collaborative research
In-iicensing
Out-licensing
History
Growth 2022
2022. 10. V1bio-Daewoong Pet MOU to co-operate on microbiome product for companion dog
2022. 08. V1bio-Ahnkook pharm MOU to co-operate on microbiome R&D
2022. 08. Establishment of a research institute (wet-lab)
2022. 08. Selection of TIPA ValueUp program by Korea Technology and Information Promotion Agency for SMEs
2022. 04. Selection of youth employment intern system participating company by the Ministry of Employment and Labor
2022. 03. Selection of KIT family company by the Korea Insitute of Toxicology
2022. 02. Selection of 2022 TIPS program by the Ministry of SMEs and Startups
Begin 2021
2021. 12. Selection of K-STARTUP venture post-support program by the Ministry of SMEs and Startups
2021. 12. Certification of the company-affiliated research institute (dry-lab)
2021. 11. Seed funding by the DAEWOONG Pharmaceuticals
2021. 11. Certification of the venture company
2021. 09. Seed funding by the Schmidt
2021. 05. Establishment of V1bio Inc